|
English
|
正體中文
|
简体中文
|
Total items :0
|
|
Visitors :
51114223
Online Users :
913
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
|
|
|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"ann lii cheng"
Showing items 1-10 of 690 (69 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2022-09-21T23:32:19Z |
B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma
|
JHE-CYUAN GUO; CHIA-LANG HSU; YEN-LIN HUANG; Chia-Chi Lin; TA-CHEN HUANG; Wu, I. Chen; Lin, Chen Yuan; Lien, Ming Yu; HUNG-YANG KUO; ANN-LII CHENG; CHIH-HUNG HSU |
| 臺大學術典藏 |
2022-09-21T23:32:18Z |
Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinoma
|
JHE-CYUAN GUO; Chia-Chi Lin; CHIA-LANG HSU; TA-CHEN HUANG; HUNG-YANG KUO; Lin, Chen Yuan; Lien, Ming Yu; ANN-LII CHENG; CHIH-HUNG HSU |
| 臺大學術典藏 |
2022-03-14T23:45:18Z |
Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma
|
YU-YUN SHAO; Chen, Pai Sheng; LIANG-IN LIN; Lee, Bin Shyun; Ling, Andrew; ANN-LII CHENG; CHIUN HSU; DA-LIANG OU |
| 臺大學術典藏 |
2022-03-14T23:44:59Z |
Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma
|
YU-YUN SHAO; HUNG-YANG KUO; YUNG-MING JENG; YAO-MING WU; HSIU-PO WANG; CHIUN HSU; CHIH-HUNG HSU; Hsu, Hey Chi; ANN-LII CHENG; Lin, Zhong Zhe |
| 臺大學術典藏 |
2022-03-14T23:44:59Z |
Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma
|
SUNG-HSIN KUO; KUN-HUEI YEH; CHUNG-WU LIN; JYH-MING LIOU; MING-SHIANG WU; Chen, Li Tzong; ANN-LII CHENG |
| 臺大學術典藏 |
2022-02-21T02:04:36Z |
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
|
Ou D.-L.; Chen C.-W.; Hsu C.-L.; Chung C.-H.; Feng Z.-R.; Lee B.-S.; ANN-LII CHENG; Yang M.-H.; Hsu C. |
| 臺大學術典藏 |
2022-02-21T02:04:36Z |
Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy
|
Huang T.-C.; Liang C.-W.; Li Y.-I.; Guo J.-C.; Lin C.-C.; Chen Y.-J.; ANN-LII CHENG; Hsu C.-H. |
| 臺大學術典藏 |
2022-02-21T02:04:35Z |
Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
|
Hsu C.-L.; Ou D.-L.; Bai L.-Y.; Chen C.-W.; Lin L.; Huang S.-F.; ANN-LII CHENG; Jeng Y.-M.; Hsu C. |
| 臺大學術典藏 |
2022-02-21T02:04:35Z |
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study
|
Qin S.; Ren Z.; Feng Y.-H.; Yau T.; Wang B.; Zhao H.; Bai Y.; Gu S.; Li L.; Hernandez S.; Xu D.-Z.; Mulla S.; Wang Y.; Shao H.; ANN-LII CHENG |
| 臺大學術典藏 |
2022-02-21T02:04:35Z |
Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT
|
Okusaka T.; Ikeda K.; Kudo M.; Finn R.; Qin S.; Han K.-H.; ANN-LII CHENG; Piscaglia F.; Kobayashi M.; Sung M.; Chen M.; Wyrwicz L.; Yoon J.-H.; Ren Z.; Mody K.; Dutcus C.; Tamai T.; Ren M.; Hayato S.; Kumada H. |
Showing items 1-10 of 690 (69 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
|
